疑似难以治疗的抑郁症的社会人口统计学和临床特征
Masami Murao1, Yasuyuki Matsumoto1, Mariko Kurihara1
1Department of Neuropsychiatry, Kyorin University Faculty of Medicine, Tokyo, Japan.
Frontiers in psychiatry
|September 5, 2024
概括
难以治疗的抑郁症 (DTD) 涉及主要抑郁症,双相情感障碍和下值抑郁症. 了解这些特征是有效,个性化的治疗策略的关键.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 难以治疗的抑郁症 (DTD) 包括患有持续性抑郁症的患者,对标准治疗没有反应.
- 对于DTD患者的特定社会人口统计和临床概况的了解仍然很少.
- 现实世界的临床环境需要更好地描述DTD患者群体的特征.
研究的目的:
- 确定疑似难以治疗的抑郁症 (DTD) 患者的社会人口统计和临床概况.
- 了解DTD患者群体中的诊断环境.
- 在DTD中确定与不同诊断类别相关的临床特征.
主要方法:
- 在Kyorin大学医院对122名被评估为怀疑DTD的患者进行了回顾性分析 (2014年10月 - 2018年9月).
- 纳入标准:持续性抑郁症对常规抗抑郁药物治疗没有反应.
- 基于DSM-IV-TR标准的诊断,包括像蒙哥马利-阿斯伯格抑郁症评分表 (MADRS) 这样的评估.
主要成果:
- 该研究包括被诊断患有严重抑郁症 (MDD) (41.8%),双相情感障碍 (BD) (28.7%) 和下值抑郁症 (29.5%) 的患者.
- 观察到高比例的精神伴随性疾病,包括焦虑症 (>30%) 和人格障碍 (>50%).
- 与BD和下值抑郁症组相比,MDD组的MADRS得分显著更高 (p<0.01).
结论:
- 疑似DTD的特点是MDD,BD和下值抑郁症的混合.
- 这些发现凸显了DTD患者中精神病并发症的显著存在.
- 彻底的诊断评估和个性化治疗策略对于管理疑似DTD至关重要.
相关概念视频
Depressive Disorders: Etiology
59
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
59
Depressive Disorders: MDD and Dysthymia
70
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
70
Depression: Overview
228
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
228
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Personality Disorders: Paranoid and Schizoid
35
Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...
Paranoid Personality Disorder
Paranoid personality disorder is...
35
Diagnostic and Statistical Manual of Mental Disorders (DSM)
49
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
49


